Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Neurocrit Care. 2020 Oct;33(2):565–574. doi: 10.1007/s12028-020-00932-4

Table 1.

Patient characteristics

Category Variable Value
Number of patients 471
Length of hospital stay: days, median (IQR) 16 (9 – 26)
Length of ICU stay: days, median (IQR) 9 (5 – 16)
M In-hospital mortality: n (%) 128 (27.2%)
B Burst Suppression Burden: median % (IQR) 9% (0% – 60%)
D Propofol: mg/kg, median (IQR) 230.5 (86.7 – 570.4)
Patient covariates including critical illness (C) Age: year, median (IQR) 61 (50 – 72)
Gender: n (%) Female 233 (49.5%); Male 238 (50.5%)
Smoker: n (%) 225 (47.8%)
Alcohol: n (%) 125 (26.5%)
Substance abuse: n (%) 57 (12.1%)
APACHE II: median (IQR) 23 (20 – 27)
CCI: median (IQR) 3 (1 – 6)
Initial Glasgow Coma Scale score: median (IQR) 7 (3 – 13)
Premorbid modified Rankin Score: median (IQR) 0 (0 – 2)
Structural brain injury: n (%) 295 (62.6%)
Hypertension: n (%) 252 (53.5%)
Respiratory failure: n (%) 182 (38.6%)
Seizures / status epilepticus on presentation: n (%) 106 (22.5%)
Hemorrhagic stroke: n (%) 94 (20.0%)
Cardiovascular accident: n (%) 92 (19.5%)
Subarachnoid hemorrhage: n (%) 83 (17.6%)
Septic shock: n (%) 76 (16.1%)
Toxic metabolic encephalopathy: n (%) 74 (15.7%)
History of seizure: n (%) 72 (15.3%)
Subdural hematoma: n (%) 49 (10.4%)
CNS infection or inflammation: n (%) 48 (10.2%)
Ischemic stroke: n (%) 40 (8.5%)
Cardiac failure: n (%) 39 (8.3%)
Renal failure: n (%) 35 (7.4%)
Brain tumor: n (%) 30 (6.4%)
Brain Surgery: n (%) 29 (6.2%)
Malignancy solid tumors hematologic: n (%) 27 (5.7%)
Liver failure: n (%) 24 (5.1%)
Primary psychiatric disorder: n (%) 20 (4.2%)
CNS Cancer: n (%) 15 (3.2%)
Endocrine emergency: n (%) 10 (2.1%)
Primary hematological disorder: n (%) 9 (1.9%)
Systemic hemorrhage: n (%) 3 (0.64%)